GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Parexel International Corporation (PRXL) [hlAlert]

Rating:
Buy PRXL
up 151.16 %

Parexel International Corporation (PRXL) rated Buy with price target $38 by Ladenburg Thalmann

Posted on: Thursday,  Aug 7, 2008  1:25 PM ET by Ladenburg Thalmann

Ladenburg Thalmann rated Buy Parexel International Corporation (NASDAQ: PRXL) on 08/07/2008. Previously Ladenburg Thalmann rated Buy Parexel International Corporation (NASDAQ: PRXL) on
07/17/2008., when the stock price was $27.56. Since then, Parexel International Corporation has gained 151.16% as of 01/25/2016's recent price of $69.22.
If you would have followed the previous Ladenburg Thalmann's recommendation on PRXL, you would have gained 151.16% of your investment in 2748 days.

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/7/2008 1:25 PM Buy
None
32.34 38.00
as of 12/24/2008
1 Week down  -28.64 %
1 Month down  -13.83 %
3 Months up  7.59 %
1 YTD down  -15.34 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/17/2008 9:25 AM Buy
None
27.56 31.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy